The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Rebif was produced by Merck KGaA.
treatment Rebif (interferon beta 1a).
The German company had been looking for additional pipeline candidates to bolster its MS franchise, currently led by $2.4bn-a-year blockbuster Rebif (interferon beta-1a). . ... Like other interferon drugs, Rebif is facing growing competition from a new
which was one of the originators behind Merck Serono's big-selling MS treatment Rebif (interferon beta-1a) and cancer drug Erbitux (cetuximab).
Sales of flagship MS treatment Rebif (interferon beta-1a) fell 3.4 per cent to 460m as competition from new orally-active treatments such as Biogen Idec's Tecfidera (dimethyl glutamate)
for key products, such as big selling multiple sclerosis (MS) treatment Rebif (interferon beta-1a), and a more challenging pharma market.
[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]
For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...